Plasmodium falciparum resistant to chloroquine and to pyrimethamine in Comoros

Parasite

Volumn 11, Issue 4, 2004, Pages 419-423

  Randrianarivelojosia, M ^a,b   Raherinjafy, R H ^a   Migliani, R ^a,c   Mercereau Puijalon, O ^d   Ariey, F ^a   Bedja, S A ^e  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c SERVICE DE SANTÉ DES ARMÉES   (France)

^d INSTITUT PASTEUR   (France)

^e Dir Lutte Contre Les Endemies L   (Comoros)

Author keywords

Chloroquine; Comoros; Malaria; Plasmodium falciparum; Resistance

Indexed keywords

CHLOROQUINE; PYRIMETHAMINE;

ARTICLE; CHILD; CLINICAL ARTICLE; COMOROS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; IN VIVO STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; TREATMENT FAILURE; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM;

EID: 10644295511     PISSN: 1252607X     EISSN: None     Source Type: Journal    
DOI: 10.1051/parasite/2004114419     Document Type: Article

References (26)

1. ARIEY F., CHALVET W., HOMMEL D., PENEAU C., HULIN A., MERCEREAU-PUIJALON O., DUCHEMIN J.B., SARTHOU J.L., REYNES J.M. & FANDEUR T. Plasmodium falciparum parasites in French Guiana: limited genetic diversity and high selfing rate. American Journal of Tropical Medicine and Hygiene, 1999, 61, 978-985.
2. ARIEY F., RANDRIANARIVELOJOSIA M., DUCHEMIN J.B., RAKOTON-DRAMARINA D., OULEDI A., ROBERT V., JAMBOU R., JAHEVITRA M., ANDRIANANTENAINA H., RAHARIMALALA L. & MAUCLERE P. Plasmodium falciparum pfcrt K76T mutation mapping: a useful tool for malaria control strategy in Madagascar. Journal of Infectious Diseases, 2002, 185, 710-712.
3. BLANCHY S. & BENTHEIN F. In vivo chemosensitivity of Plasmodium falciparum in the Islamic Federal Republic of the Comoros. Bulletin de la Société de Pathologie Exotique, 1989, 82, 493-502.
4. BZIK D.J., LI W.B., HORII T. & INSELBURG J. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proceedings of the National Academy of Sciences USA, 1987, 84, 8360-8364.
5. COWMAN A.F., MORRY M.J., BIGGS B.A., CROSS G.A. & FOOTE S.J. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proceedings of the National Academy of Sciences USA, 1988, 85, 9109-9113.
6. DJIMDE A., DOUMBO O.K., CORTESE J.F., KAYENTAO K., DOUMBO S., DIOURTE Y., DICKO A., SU X.Z., NOMURA T., FIDOCK D.A., WELLEMS T.E., PLOWE C.V. & COULIBALY D. A molecular marker for chloroquine-resistant falciparum malaria. New England Journal of Medicine, 2001, 344, 257-263.
7. DORSEY G., KAMYA M.R., SINGH A. & ROSENTHAL P.J. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. Journal of Infectious Diseases, 2001, 183, 1417-1420.
8. EICHENLAUB D. & POHLE H.D. A case of chloroquine-resistant (R1) falciparum malaria from the East African Comoros Islands. Infection, 1980, 8, 90-92.
9. FEILLET N., AGNAMEY P., BRASSEUR P. & DRUILHE P. In vivo resistance of Plasmodium falciparum to chloroquine in Anjouan (Comoros). Bulletin de la Société de Pathologie Exotique, 1993, 86, 48-51.
10. FIDOCK D.A., NOMURA T., TALLEY A.K., COOPER R.A., DZEKUNOV S.M., FERDIG M.T., URSOS L.M., SIDHU A.B., NAUDE B., DEITSCH K.W., SU X.Z., WOOTTON J.C., ROEPE P.D. & WELLEMS T.E. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular Cell, 2000, 6, 861-871.
11. FOOTE S.J., KYLE D.E., MARTIN R.K., ODUOLA A.M., FORSYTH K., KEMP D.J. & COWMAN A.F. Several alleles of multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature, 1990, 345, 255-258.
12. HYDE J.E. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacology and Therapeutics, 1990, 48, 45-59.
13. KYOSIIMIRE-LUGEMWA J., NALUNKUMA-KAZIBWE A.J., MUJUZI G., MULINDWA H., TALISUNA A. & EGWANG T.G. The Lys-76-Thr mutation in PfCRT and chloroquine resistance in Plasmodium falciparum isolates from Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2002, 96, 91-95.
14. KUBLIN J.G., DZINJALAMALA F.K., KAMWENDO D.D., MALKIN E.M., CORTESE J.F., MARTINO L.M., MUKADAM R.A., ROGERSON S.J., LESCANO A.G., MOLYNEUX M.E., WINSTANLEY P.A., CHIMPENI P., TAYLOR T.E. & PLOWE C.V. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Journal of Infectious Diseases, 2002, 185, 380-388.
15. MINODIER P., LANZA-SILHOL F., PIARROUX R., GARNIER J.M., DUMON H. & UNAL D. Imported pediatric malaria in Marseille. Archives de Pediatrie, 1999, 6, 935-943.
16. OULEDI A. Epidemiology and control of malaria in the Federal Islamic Republic of Comoros. Cahiers Santé, 1995, 5, 368-371.
17. PETERSON D.S., WALLIKER D. & WELLEMS T.E. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proceedings of the National Academy of Sciences USA, 1988, 85, 9114-9118.
18. RANDRIANARIVELOJOSIA M., SAHONDRA-HARISOA J.L., RABARIJAONA L.P., RAHARIMALALA L.A., RANAIVO L.H., PIETRA V., DUCHEMIN J.B., RAKOTOMANANA F., ROBERT V., MAUCLERE P. & ARIEY F. In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar Parassitologia, 2002, 44, 141-147.
19. RANDRIANARIVELOJOSIA M., ARIEY F., RAHARIMALALA L.A., PARZY D., ROGIER C. & JAMBOU R. Current absence of pyrimethamine-resistance of Plasmodium falciparum in Madagascar. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2002b, 96, 557-559.
20. RANDRIANARIVELOJOSIA M., RATSIMBASOA A., RANDRIANASOLO L., RANDRIANARIJAONA A. & JAMBOU R. In vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar. East African Medical Journal, 2002c, 79, 237-241.
21. RANFORD-CARTWRIGHT L.C., JOHNSTON K.L., ABDEL-MUHSIN A.M., KHAN B.K. & BABIKER H.A. Critical comparison of molecular genotyping methods for detection of drug-resistant Plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2002, 96, 568-572.
22. RASON M.A., ARIEY F., RAFIDIMANANTSOA L., ANDRIANANTENAINA B.H., SAHONDRA-HARISOA J.L. & RANDRIANARIVELOJOSIA M. Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests. Parasite, 2002, 9, 247-253.
23. TALISUNA A.O., KYOSIIMIRE-LUGEMWA J., LANGI P., MUTABINGWA T.K., WATKINS W., VAN MARCK E., EGWANG T. & D'ALESSANDRO U. Role of the pfcrt codon 76 mutation as a molecular marker for population-based surveillance of chloroquine (CQ)-resistant Plasmodium falciparum malaria in Ugandan sentinel sites with high CQ resistance. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2002, 96, 551-556.
24. VON SEIDLEIN L, DURAISINGH M.T., DRAKELEY C.J., BAILEY R., GREENWOOD B.M. & PINDER M. Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1997, 91, 450-453.
25. ZINDROU S., DAO L.D., XUYEN P.T., DUNG N.P., SY N.D., SKOLD O. & SWEDBERG G. Rapid detection of pyrimethamine susceptibility of Plasmodium falciparum by restriction endonuclease digestion of the dihydrofolate reductase gene. American Journal of Tropical Medicine and Hygiene, 1996, 54, 185-188.
26. WHO. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in area with intense transmission. Geneva: World Health Organization. WHO/MAL96.1077, 1996.